Journal Article

Immunosuppressive effects of circulating bile acids in human endotoxemia and septic shock: patients with liver failure are at risk

Kiehntopf, Michael, Neugebauer, Sophie, Leonhardt, Julia, Hohberger, Frank-Stephan, Mihaylov, Diana, Bode, Christian, David, Sascha, Wagener, Frank A. D. T. G., Pickkers, Peter, Leonhardt, Silke, Kunze, Julia, Stahl, Klaus, Bauer, Michael, Rubio, Ignacio, Dorresteijn, Mirrin J.

2023

Overview

Background Sepsis-induced immunosuppression is a frequent cause of opportunistic infections and death in critically ill patients. A better understanding of the underlying mechanisms is needed to develop targeted therapies. Circulating bile acids with immunosuppressive effects were recently identified in critically ill patients. These bile acids activate the monocyte G-protein coupled receptor TGR5, thereby inducing profound innate immune dysfunction. Whether these mechanisms contribute to immunosuppression and disease severity in sepsis is unknown. The aim of this study was to determine if immunosuppressive bile acids are present in endotoxemia and septic shock and, if so, which patients are particularly at risk. Methods To induce experimental endotoxemia in humans, ten healthy volunteers received 2 ng/kg E. coli lipopolysaccharide (LPS). Circulating bile acids were profiled before and after LPS administration. Furthermore, 48 patients with early (shock onset within < 24 h) and severe septic shock (norepinephrine dose > 0.4 μg/kg/min) and 48 healthy age- and sex-matched controls were analyzed for circulating bile acids. To screen for immunosuppressive effects of circulating bile acids, the capability to induce TGR5 activation was computed for each individual bile acid profile by a recently published formula. Results Although experimental endotoxemia as well as septic shock led to significant increases in total bile acids compared to controls, this increase was mild in most cases. By contrast, there was a marked and significant increase in circulating bile acids in septic shock patients with severe liver failure compared to healthy controls (61.8 µmol/L vs. 2.8 µmol/L, p  = 0.0016). Circulating bile acids in these patients were capable to induce immunosuppression, as indicated by a significant increase in TGR5 activation by circulating bile acids (20.4% in severe liver failure vs. 2.8% in healthy controls, p  = 0.0139). Conclusions Circulating bile acids capable of inducing immunosuppression are present in septic shock patients with severe liver failure. Future studies should examine whether modulation of bile acid metabolism can improve the clinical course and outcome of sepsis in these patients. Graphical abstract

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Acids / Apheresis / Bile / Bile acids / Bile Acids and Salts / Care and treatment / Cholestasis / Critical care / Critical Care Medicine / Critical Illness / Cytokines / Dosage and administration / Drug therapy / E coli / Emergency Medicine / Endotoxemia - complications / Escherichia coli / Gallbladder diseases / GPBAR1 / Health aspects / Humans / Immunotherapy / Infection / Intensive / Intensive care / Laboratories / Lipopolysaccharide / Lipopolysaccharides / Liver / Liver Failure / LPS / Medicine / Medicine & Public Health / Monocytes / Patient outcomes / Prevention / Proteins / Risk factors / Sepsis / Septic shock / Shock, Septic - metabolism / Statistical analysis / TGR5 / Variance analysis